Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1778-1789
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1778
Table 4 Discrimination measures and hazard ratios evaluated among four scoring systems
Scoring system
CGMH
AJCC 8th edition
Tokyo
Taipei
Estimate
SE
Estimate
SE
Estimate
SE
Estimate
SE
Measures of discrimination
Harrell’s CH0.6170.010.6170.010.6130.0110.5620.01
Gonen and Heller’s CGH0.5990.0090.5860.0090.5870.015390.009
Royston & Sauerbrei’s D 0.6720.0660.5770.0650.5890.0660.2920.067
Prognostic scoring systemHR95%CI of HRP valueHR95%CI of HRP valueHR95%CI of HRP valueHR95%CI of HRP value
CGMH: Low11111
Intermediate, high1.811.50-2.19< 0.00011.351.08-1.690.0091.551.04-2.290.031.211.01-1.450.039
AJCC 8th edition:2.742.25-3.34< 0.00011.691.29-2.21< 0.0011.71.16-2.490.0071.431.08-1.880.012
IA1, IB, II, IIIA, IIIB2.081.57-2.76< 0.00012.641.76-3.96< 0.00011.791.31-2.44< 0.001
Tokyo: 01, 1, 2, 3, 4, 53.152.41-4.12< 0.00014.142.70-6.36< 0.00011.260.97-1.640.079
Taipei: 01, 1, 2, 3, 44.12.54-6.63< 0.0001